Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Societal CDMO Inc | SCTL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.10 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.10 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.26 - 1.28 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.10 | USD |
Societal CDMO Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 219.01M | 104.79M | - | 94.64M | -13.27M | -0.13 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Societal CDMO News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SCTL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 1.08 | 1.10 | 1.08 | 1.09 | 566,663 | 0.02 | 1.85% |
| 3 Months | 0.3427 | 1.10 | 0.32 | 0.9944681 | 1,324,320 | 0.7573 | 220.98% |
| 6 Months | 0.37 | 1.10 | 0.26 | 0.8559189 | 683,195 | 0.73 | 197.30% |
| 1 Year | 0.86 | 1.28 | 0.26 | 0.7852369 | 464,944 | 0.24 | 27.91% |
| 3 Years | 2.02 | 2.10 | 0.26 | 0.8844615 | 279,908 | -0.92 | -45.54% |
| 5 Years | 2.02 | 2.10 | 0.26 | 0.8844615 | 279,908 | -0.92 | -45.54% |
Societal CDMO Description
| Recro Pharma, Inc. is registered with the U.S. Security and Exchange Commission . Recro Pharma, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Recro Pharma, Inc.. Recro Pharma Inc is a contract development and manufacturing company. The company is engaged in the development, formulation, regulatory support, manufacturing, and packaging of oral solid dose drug products. |
